Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 794 across all filing types
Latest filing 2022-05-09 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial results
Regulatory Filings Classification · 95% confidence The document text is extremely short (54 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of content, this cannot be classified as a report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2022-05-09 English
General updates
Regulatory Filings
2022-05-05 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure under Regulation 31(4) listing promoters and promoter groups of Panacea Biotec Limited for the financial year ending 31-Mar-2022. It is a regulatory disclosure about shareholding or promoter details rather than a financial report or announcement of voting results. The document length is short (2041 characters) and contains no financial statements or management commentary. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory filing related to shareholding disclosures under a specific regulation. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory disclosures that do not fit other categories.
2022-04-11 English
General updates
Regulatory Filings
2022-04-05 English
General updates
Regulatory Filings Classification · 90% confidence The document text is extremely short (113 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. According to the rules, such minimal or non-informative content defaults to Regulatory Filings (RNS) as a fallback category.
2022-04-05 English
General updates
Regulatory Filings
2022-04-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.